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test the claim that any set of values are in fact utility weights.
Secondly, quality-adjustment weights play a crucial role in deter-
mining cost-utility ratios. Different weights are elicited when 
different utility measurement techniques are used, so that cost-
utility ratios can be susceptible to systematic bias depending
upon the choice of method used. Examples of this weakness are
provided from the published literature and reveal the extent to
which cost/QALY ratios can vary in the analysis of a single inter-
vention. Finally, the paper argues for a less technically demand-
ing approach to the determination of preferences in the valuation
of health. RESULTS: It speciﬁes the minimum requirements for
any quality-adjustment index and proposes the use of stated pref-
erence methods that have an established theoretical basis but that
are also grounded in the practical day-to-day experiences of ordi-
nary people. The case is demonstrated using VAS data collected
in a UK national postal survey (n = 682) designed to establish
values for EQ-5D health states but where paired comparisons
methods have been used to establish health state values. CON-
CLUSIONS: The paper concludes that there is no basis for the
continued reliance on utility weights in calculating cost/QALY
ratios.
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Discrete choice models are used to elicit preference data from
patients, medical and allied healthcare experts, and representa-
tive community samples. The resulting data are used in eco-
momic evaluation studies to derive health utility values. In most
reported studies, statistical methodology issues are usually
glossed over and standard assumptions are made. However, sta-
tistical properties of discrete choice models present some inter-
esting challenges to these more traditional views. OBJECTIVES:
In this presentation we focus on two areas fundamental to the
conduct of any discrete choice study: the use of orthogonal
designs in experimental design and interpretation of model
results, and highlight some misconceptions surrounding their
current use. METHODS: More speciﬁcally, we highlight, with
examples, that important properties of orthogonal designs
assumed to underlie methods used in discrete choice studies don’t
hold in general. RESULTS: We also discuss implications of
applying the usual random effects or conditional models to 
discrete choice data. In both cases we discuss alternative
approaches. CONCLUSIONS: The intention of this presentation
is to inform researchers about these potential shortcomings in
statistical methodology which is widely applied to discrete choice
studies, and to encourage the development and use of alterna-
tive methods which may improve validity.
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OBJECTIVES: Derive Chronic Disease Scores (CDS) among
Alberta seniors from population-based automated pharmacy
data. METHODS: Different types of medications prescribed
during 2001/2002 for the treatment and management of chronic
conditions were obtained from Alberta Blue Cross (ABC) claims
database. The medications were clustered into 25 therapeutic
classes to indicate the presence of a chronic illness based on the
criteria proposed by Clark. The study population was composed
of all Alberta residents aged 65 or over who were registered with
the Alberta Health Care Insurance Plan (AHCIP) continuously
from June 30, 2001 to June 30, 2002. Registration with the
AHCIP is mandatory for all Alberta residents. Individuals were
excluded if they had been diagnosed with any malignancy, tuber-
culosis or HIV during the study period. Three outcomes: total
cost, outpatient care cost and the number of primary care visits
in 2002/2003, were derived from AHCIP databases. Linear
regression models were utilized to estimate parameters associ-
ated with age, gender and each medication class for each of the
three outcomes. RESULTS: Records for 221,230 seniors were
used to estimate the empirical weights for calculating CDS. With
the weights an estimate of an individual’s one-year predicted
score for cost and visits can be obtained. For example, a 
72-year-old man receiving medications for rheumatoid 
arthritis would have an estimated one-year total cost of
$2591.96 (3447.66(intercept)+592.62(male)-2868.49(age
65–74)+1420.17(rheumatoid arthritis)). Using the R-square cri-
teria, our CDS prospectively explained 11.9% of the variance in
total cost, 40.7% of outpatient cost, and 10.2% in primary care
visit. These are higher in costs but lower in visits comparing with
Clark’s results. CONCLUSIONS: We estimated CDS with the
same method proposed by Clark using Alberta data. The results
showed that these models can be generally used to measure
disease severity and to predict the prospective health service cost
and utilization for different populations.
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OBJECTIVES: To develop a scale of Nutrition Related Quality
of Life (NRQoL) in healthy children of 6 to 12 years old to be
used in nutritional interventional studies in Spain. METHODS:
The process of development of the DANN scale (Escala DAnone
de calidad de vida relacionada con la Nutrición en Niños/as)
included a literature review to deﬁne potential dimensions, a
qualitative research phase for the elicitation of concepts includ-
ing interviews to clinicians, psychologists, Focus Group with the
target population and expert meetings for the item generation
(version one). The face and content validity was analyzed by
means of a cognitive debrieﬁng process (version two). The quan-
titative research phase consisted of an evaluation of the scale in
125 children followed by a standard item reduction (version 3).
This new version was administered to 500 children from differ-
ent sites in Spain to evaluate the psychometric properties (relia-
bility, construct-related and content-related validity) of the ﬁnal
version. RESULTS: The internal consistency of the DANN self-
administered scale appears satisfactory (Cronbach’s alpha =
0.78). The underlying dimension structure of the scale was con-
ducted by a principal component analysis with varimax rotation.
The three ﬁrst dimensions explained 42% of the total variance
and conceptually corresponded to the dimensions initially
deﬁned (construct-related validity). The ﬁrst dimension gathers
the attitudes and beliefs related with healthy nutrition, consist-
ing of ten items (23%). The second dimension is related to the
physical well-being and includes six items (11%). The third
dimension is related to the psysich well-being and contains three
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items (8%). Two different versions of the scale were developed
according to the age of the children. CONCLUSIONS: The
DANN scale is the ﬁrst questionnaire of NRQoL developed in
Europe and can be a useful tool for the evaluation of the effects
of a nutritional intervention in healthy children.
PMC21
AN EXPLORATION OF THE DISCREPANCIES BETWEEN
HEALTH STATE VALUATIONS OF PATIENTS AND THE
GENERAL POPULATION
Ratcliffe J, Brazier J, Palfreyman S, Michaels J
Shefﬁeld University, Shefﬁeld, UK
OBJECTIVES: Investigate the relationship between patients’ val-
uations of their own health using the standard gamble (SG) and
EQ-5D visual analogue scale (VAS) and general population
values of the same health states within the context of a ran-
domised controlled trial to compare alternative treatments for
varicose veins. METHODS: Patients (n = 131) were surveyed at
randomisation and at 12 months to assess their own health status
using the SG. Patients also completed the SF-36 and the EQ-5D
at the same time-points. Responses to the SF-36 were converted
into SF-6D using the SG algorithms developed by Brazier and
colleagues, version one and two, based upon general population
values. RESULTS: At both time points, the SG produced a higher
mean score than either of the SF-6D algorithms although the dif-
ference between patient and general population values was far
more pronounced for version two [Baseline mean (SD) version
one: 0.913 (0.072), version two: 0.730 (0.108), patients’ value
0.942 (0.116); 12 months mean (SD) version one: 0.912 (0.082),
version two: 0.736 (0.108), patients’ value 0.924 (0.115)]. Sim-
ilarly, the VAS produced a higher mean score than either of the
algorithms based upon general population values [Baseline mean
(SD) SF-6D VAS algorithm: 0.668 (0.173), EQ-5D VAS algo-
rithm: 0.743 (0.173), patients’ value 0.762 (0.167); 12 months
mean (SD) SF-6D VAS algorithm: 0.676 (0.191), EQ-5D VAS
algorithm: 0.771 (0.155), patients’ value 0.781 (0.104)]. CON-
CLUSIONS: For the condition of varicose veins, the magnitude
of differences in health state valuations due to treatment appears
to be small compared with the magnitude of differences exhib-
ited between alternative sources of values and the effect of dif-
ferent valuation systems. The variant of elicitation technique
used to elicit SG values may be more important than the source
of those values in revealing discrepancies.
PMC22
REVIEW OF INSTRUMENTS MEASURING TREATMENT
SATISFACTION WITH MEDICATION
Gandra SR1, Parasuraman B2, Lawrence LW1, Humble LJ1
1The University of Louisiana at Monroe, Monroe, LA, USA;
2AstraZeneca LP, Wilmington, DE, USA
OBJECTIVES: Treatment satisfaction with medication (TSM), a
patient reported outcome, is an important factor in promoting
patient adherence to prescription regimens. This review evalu-
ates published instruments measuring TSM across various
disease states. METHODS: A systematic literature review of
Medline from 1980–2004 was conducted. Instruments measur-
ing satisfaction with important attributes of treatment, as
opposed to one-item global measures of satisfaction, were
selected for review. The following ﬁelds were abstracted from
articles for each instrument and summarized: applicable disease
state; mode of administration; modules, domains and items;
response options; method used for item development/selection;
psychometric properties; and practicality. Standard psychomet-
ric measures including internal consistency and test-retest relia-
bility, validity and responsiveness were chosen as evaluative cri-
teria. Alpha ≥0.7 was chosen as acceptable for reliability.
RESULTS: Eleven disease-speciﬁc instruments were identiﬁed
(SATQ, PSAM, MTSM, DTSQ, PPMQ, PSIT, EDITS, PSQ, TSS-
IOP, ITSQ, HIVTSQ), in addition to one generic instrument
(TSQM). All these instruments are self-administered but vary
widely in items, domains, and psychometric measures. The
number of items range from eight (DTSQ)–26 (SATQ) and the
number of domains one–eight. All instruments except PSQ and
EDITS were developed through patient reports. All measured
internal consistency. Of the 12 instruments evaluated, only 6
measured test-retest reliability; 3 of the 6 (ITSQ, SATQ, and
PSIT) had domains with low reproducibility (alpha <0.7). Only
PPMQ reported responsiveness. Only MTSM measured patient
expectations at baseline, and expectations, weighted by subjec-
tive importance of symptoms and the actual treatment experi-
ence, were used to derive TSM. CONCLUSIONS: This review
determined that most TSM instruments have acceptable psycho-
metric properties. However, expectations with treatment and
clinical interpretation of change scores are missing from these
measures. Further research is required to develop well-supported
conceptual models of TSM, TSM measures in different thera-
peutic areas, and validation of existing measures in different 
populations.
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OBJECTIVES: Assess the state of the art of the studies on eco-
nomic evaluations in health care in Mexico, regarding their
methodological quality and tendencies. METHODS: Systematic
review of the research on economic evaluation in health pub-
lished in Mexico from January 1983 to July 2004. We searched
multiple electronic databases, hand-searched key journals and
personally contacted investigators in June 2004. Two health
economist reviewers independently assessed the relevante of
retrieved articles, described the methods of included studies and
extrated data that were summarized. Used Drummond criteria;
a) to classify in completes (CEE) or parcial evaluation economic
(PEE), and b) assessment criteria in quality of methodology. The
analysis of the publications characteristics was made with
descriptive statistics. Limitation: Included only published studies
and possible omitted studies subjectivity in judging certain items.
RESULTS: Ninety-six match with inclusion criteria, 24 of them
were CEE, 69 were PEE and 3 were editorials. The number of
CEE in Mexico increased greatly between 1983–1993 (three
studies) and 1994-May 2004 (21 studies). We reviewed 23 CEE
studies in extenso. The technique most used was cost-effective-
ness (83%). In terms of methodological quality the 78% do not
mentioned study perspective, 56.52% do not reported sensitiv-
ity analyses, 58.34% do not reported had used the discount rate
when it was necessary and 60% do not report clearly the costs.
CONCLUSIONS: The study results reveal an increase in CEE in
México in the last ten years, with low quality methodology.
There is a need to elaborate and validate guidelines for economic
evaluation in health for Mexico by uniﬁed quality standards in
order to have internal and external validity.
